Ivan Cheung, Eisai’s retiring US chair, global Alzheimer’s leader
Eisai’s US chair, global Alzheimer’s leader to retire weeks after Leqembi approval
Ivan Cheung, the global leader of Eisai’s Alzheimer’s apparatus, will retire at the end of July, the Japanese drugmaker said Tuesday, just four days after …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
